Related references
Note: Only part of the references are listed.A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study
Shuichi Miyawaki et al.
BLOOD (2011)
Which AML Subsets Benefit From Leukemic Cell Priming During Chemotherapy? Long-Term Analysis of the ALFA-9802 GM-CSF Study
Xavier Thomas et al.
CANCER (2010)
The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication
Aline Renneville et al.
BLOOD (2009)
Clofarabine for the treatment of adult acute myeloid leukemia
Xavier Thomas et al.
FUTURE ONCOLOGY (2009)
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Systematic Review and Meta-analysis of Prospective Clinical Trials
John Koreth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission:: Collaborative study between the German AML intergroup and CIBMTR
Richard F. Schlenk et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine:: A Cancer and Leukemia Group B study
Andreas Neubauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F. Schlenk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia
Rosemary E. Gale et al.
BLOOD (2008)
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission
Martin S. Tallman et al.
BLOOD (2007)
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
Jan J. Cornelissen et al.
BLOOD (2007)
Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia:: a trial by the Acute Leukemia French Association (ALFA) Group
X. Thomas et al.
LEUKEMIA (2007)
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222
JO Moore et al.
BLOOD (2005)
Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission - A metaanalysis
M Yanada et al.
CANCER (2005)
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype:: A cancer and leukemia group B study
SS Farag et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22):: Results from CALGB 8461
JC Byrd et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Randomized comparison of double induction and timed-sequential induction to a 3+7 induction in adults with AML:: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study
S Castaigne et al.
BLOOD (2004)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML):: a survey of 110 cases from the French AML Intergroup
J Delaunay et al.
BLOOD (2003)
A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML):: a survey of 161 cases from the French AML Intergroup
S Nguyen et al.
BLOOD (2002)
Share Paper
